“I think at the moment we’re just going to have a specific trial with a controlled sample of people and then we’ll decide based on the trial how far we want to roll that out. But it’s pleasing that we are one of the forces that’s taking this on,” Bedfordshire’s deputy chief constable, Trevor Rodenhurst said.
Cab drivers for Edinburgh’s Central Taxis have agreed to carry naloxone as part of a campaign to reduce drug deaths… As well as drivers carrying the opioid overdose reversal drug, one of the taxis will be emblazoned – inside and out – to carry the #StopTheDeaths message.
The podcast covers several key issues about naloxone, including how it works, how to administer it, the law, and the latest research. They talk about the role of naloxone in reducing drug-related deaths in the UK and the implications for drug policy.
A new project being trialled in Bolton and Bury is hoping to save lives by training people how to use a drug that reverses the effects of an overdose. Under the project, a team of peers take Naloxone out on to the streets and train members of the community in how to use it.
University of Stirling Substance Use expert Professor Catriona Matheson is launching a new partnership with the pharmacy profession to help drive down drug deaths. The aim of this initiative is to bring together stakeholders in the pharmacy profession across Scotland to explore how to drive change and improve health with the ultimate objective of reducing deaths. The event will bring together topic specialists, practising pharmacists and leaders from across the pharmacy profession.
As the drug-overdose epidemic continues to worsen, the American Medical Association (AMA) is maintaining its pressure on regulators, legislators and manufacturers to expand availability to naloxone. This includes making the opioid-related overdose-reversing drug available over the counter (OTC). The Biden administration is considering such a move, according to Health and Human Services Secretary Xavier Becerra remarks that were strongly supported by the AMA.